Found: 70
Select item for more details and to access through your institution.
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01181-y
- By:
- Publication type:
- Article
Serum neurofilament indicates that DBS surgery can cause neuronal damage whereas stimulation itself does not.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05117-x
- By:
- Publication type:
- Article
Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 5, p. 392, doi. 10.3390/jpm11050392
- By:
- Publication type:
- Article
Circulating Dickkopf1 Parallels Metabolic Adaptations and Predicts Disease Trajectories in Patients With COVID-19.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. 3370, doi. 10.1210/clinem/dgac514
- By:
- Publication type:
- Article
Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13759, doi. 10.3390/ijms232213759
- By:
- Publication type:
- Article
Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12361, doi. 10.3390/ijms232012361
- By:
- Publication type:
- Article
Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8042, doi. 10.3390/ijms22158042
- By:
- Publication type:
- Article
SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 684, doi. 10.3390/vaccines12060684
- By:
- Publication type:
- Article
Insights from Real-World Practice: The Dynamics of SARS-CoV-2 Infections and Vaccinations in a Large German Multiple Sclerosis Cohort.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 265, doi. 10.3390/vaccines12030265
- By:
- Publication type:
- Article
Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1464, doi. 10.3390/vaccines11091464
- By:
- Publication type:
- Article
Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01209-w
- By:
- Publication type:
- Article
Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01209-w
- By:
- Publication type:
- Article
Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01209-w
- By:
- Publication type:
- Article
Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.897748
- By:
- Publication type:
- Article
The need for a strategic therapeutic approach: multiple sclerosis in check.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223211063032
- By:
- Publication type:
- Article
The need for a strategic therapeutic approach: multiple sclerosis in check.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223211063032
- By:
- Publication type:
- Article
Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319835136
- By:
- Publication type:
- Article
Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting.
- Published in:
- Therapeutic Advances in Chronic Disease, 2019, v. 10, p. 1, doi. 10.1177/2040622319835136
- By:
- Publication type:
- Article
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221133163
- By:
- Publication type:
- Article
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221133163
- By:
- Publication type:
- Article
Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis.
- Published in:
- Frontiers in Neuroscience, 2017, p. 1, doi. 10.3389/fnins.2017.00540
- By:
- Publication type:
- Article
Molecular biomarkers in multiple sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Triangulating brain alterations in anorexia nervosa: a multimodal investigation of magnetic resonance spectroscopy, morphometry and blood-based biomarkers.
- Published in:
- Translational Psychiatry, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41398-023-02580-6
- By:
- Publication type:
- Article
Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02669
- By:
- Publication type:
- Article
Response to Hyun J.W. et al. "Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Letter to the editor regarding "Therapeutic drug monitoring of natalizumab".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Serum neurofilament light chain as a sensitive biomarker for neuromonitoring during extracorporeal membrane oxygenation.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71603-z
- By:
- Publication type:
- Article
Digital Biomarkers in Multiple Sclerosis.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 11, p. 1519, doi. 10.3390/brainsci11111519
- By:
- Publication type:
- Article
Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00056
- By:
- Publication type:
- Article
The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice.
- Published in:
- Frontiers in Neuroscience, 2020, p. N.PAG, doi. 10.3389/fnins.2020.582046
- By:
- Publication type:
- Article
Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62756-8
- By:
- Publication type:
- Article
Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1198860
- By:
- Publication type:
- Article
NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1081933
- By:
- Publication type:
- Article
Impedimetric Microfluidic Sensor‐in‐a‐Tube for Label‐Free Immune Cell Analysis.
- Published in:
- Small, 2021, v. 17, n. 5, p. 1, doi. 10.1002/smll.202002549
- By:
- Publication type:
- Article
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00605-x
- By:
- Publication type:
- Article
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 2, p. 450, doi. 10.1002/acn3.51965
- By:
- Publication type:
- Article
Associations of sNfL with clinico‐radiological measures in a large MS population.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 1, p. 84, doi. 10.1002/acn3.51704
- By:
- Publication type:
- Article
Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 10, p. 2013, doi. 10.1002/acn3.51449
- By:
- Publication type:
- Article
Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 11, p. 2199, doi. 10.1002/acn3.51206
- By:
- Publication type:
- Article
Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.715195
- By:
- Publication type:
- Article
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.701752
- By:
- Publication type:
- Article
Digital Twins for Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.669811
- By:
- Publication type:
- Article
Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease.
- Published in:
- Acta Neurologica Belgica, 2023, v. 123, n. 3, p. 917, doi. 10.1007/s13760-022-02091-z
- By:
- Publication type:
- Article
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study.
- Published in:
- Brain Pathology, 2021, v. 31, n. 6, p. 1, doi. 10.1111/bpa.12969
- By:
- Publication type:
- Article
A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 4, p. 1210, doi. 10.1007/s00415-019-09489-5
- By:
- Publication type:
- Article
CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.647428
- By:
- Publication type:
- Article
Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.650530
- By:
- Publication type:
- Article
Should We Use Clinical Tools to Identify Disease Progression?
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.628542
- By:
- Publication type:
- Article
Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00391
- By:
- Publication type:
- Article
Brain structure and neurocognitive function in two professional mountaineers during 35 days of severe normobaric hypoxia.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 10, p. 3112, doi. 10.1111/ene.15470
- By:
- Publication type:
- Article